Randomised Phase III Trial With Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotnib Followed of Capecitabine in Patients With Advanced Pancreatic Cancer.
Phase of Trial: Phase III
Latest Information Update: 01 Jul 2015
At a glance
- Drugs Capecitabine; Erlotinib; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 07 Jul 2012 The non-inferiority of treatment regimens on the primary endpoint 'Time-to-treatment-failure' has been met according to results published in Gut.
- 07 Jul 2012 Final results published in the Gut.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History